Ketamine depot - Alar Pharmaceuticals
Alternative Names: ALA-3000; Depot ketamine formulation - Alar PharmaceuticalsLatest Information Update: 11 Nov 2023
Price :
$50 *
At a glance
- Originator Alar Pharmaceuticals
- Class Amines; Analgesics; Antidepressants; Antihyperglycaemics; Antiparkinsonians; Anxiolytics; Behavioural disorder therapies; Chlorobenzenes; Cyclohexanes; General anaesthetics; Ketones; Mood stabilisers; Neuroprotectants; Neuropsychotherapeutics; Obesity therapies; Small molecules
- Mechanism of Action AMPA receptor agonists; Biogenic amine uptake modulators; Dopamine receptor agonists; Nicotinic receptor modulators; NMDA receptor antagonists; Opioid receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Depressive disorders
Most Recent Events
- 21 Aug 2023 ALA 3000 receives Notice of Eligibility of Grant in Singapore (Alar Pharmaceuticals website, October 2023)
- 07 Aug 2023 Alar Pharmaceuticals has patent pending for ALA 3000 in Chile (Alar Pharmaceuticals website, October 2023)
- 02 Aug 2023 Alar Pharmaceuticals has patent pending for ALA 3000 in European Union (Alar Pharmaceuticals website, October 2023)